SHOULDER ARTHROSCOPY (SAOOA)647
Report
- Report Number
- 1423507-2007-00083
- Event Type
- Other
- Date Received
- May 31, 2007
- Date of Event
- May 4, 2007
- Report Date
- May 31, 2007
- Manufacturer
- CARDINAL HEALTH
- Product Code
- HRX
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OR, US
- Reporter Occupation
- OTHER
Narratives
THE MANUFACTURER OF COMPONENT 0523-48, MASTISOL ADHESIVE SOLUTION, FERNDALE LABORATORY OUT OF FERNDALE MICHIGAN HAS DECLINED TO SUBMIT AN MDR. CARDINAL HEALTH IS SUBMITTING AS THE CONVENIENCE KIT PACKAGER. PER FERNDALE LABORATORY: PRODUCTION RECORDS SHOW LOT 06004B WAS MANUFACTURED IN ACCORDANCE WITH GOOD MANUFACTURING PRACTICES AND ALL LABORATORY TESTING FOR LOT 08004B MET FERNDALE LABORATORIES FINISHED PRODUCT SPECIFICATIONS FOR MASTISOL AND RESULTS WERE DEEMED ACCEPTABLE AT THE TIME OF RELEASE.
CUSTOMER REPORTS, THAT IN 4 INSTANCES WITHIN THE LAST WEEK, A PATIENT HAS EXPERIENCED DERMATITIS AT THE SITE OF SHOULDER ARTHROSCOPY AS A RESULT OF BEING EXPOSED TO 0523-48: MASTISOL ADHESIVE SOLUTION. A TOPICAL CORTISOL PRESCRIPTION WAS USED TO PREVENT ITCHING. ALL PATIENTS HAVE HAD RESOLUTION OF THE DERMATITIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SHOULDER ARTHROSCOPY (SAOOA)647 | SHOULDER ARTHROSCOPY | HRX | CARDINAL HEALTH | SOP53SAOOB | 204888 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | YR | Required Intervention |